Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Steris plans to build a new medical device testing facility

admin by admin
September 27, 2022
in News


Steris released this rendering of the medical device testing facility it plans to open in Leipzig, Germany. [Image courtesy of Steris]

Steris (NYSE: STE) plans to build a new packaging and microbiological testing facility for medical devices in Leipzig, Germany.

The facility will offer packaging testing services such as accelerated and real-time aging, transportation and integrity testing. The new location will also offer microbiological testing in collaboration with the medical device manufacturer and sterilizer’s laboratory in Radeberg.

Steris said the Leipzig packaging testing services will complement existing services offered in Galway, Ireland, and Brooklyn Park, Minnesota.

RELATED: Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits

“This investment furthers our commitment to supporting medical device manufacturers throughout all stages of the sterilization design process,” the company said in a statement. “As a critical piece of new product development, this offering ensures that medical devices meet industry requirements for sterile claim and product functionality. These services are also an important consideration when converting product from one sterilization technology to another, confirming product and packaging compatibility with the new technology.”

Steris already offers electron beam, gamma and microbiological testing services in Allershausen, Bitterfeld, and Radeberg, all in Germany.

Steris is the 26th largest medical device company in the world, according to our 2022 Medtech Big 100 ranking. The Mentor, Ohio-based sterilization and surgical products company reported nearly $4.59 billion in annual revenue and around 16,000 employees as of its most recent fiscal year.



Source link

Previous Post

Study of 9 million Swedes shows rapidly declining effectiveness of COVID vaccines against Omicron

Next Post

Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells models

Next Post

Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells models

Recommended

Nasal antibodies decline nine months after COVID-19 infection, study finds

9 months ago

MDIC updates CAPA framework for medical device manufacturers

3 months ago

How to Choose the Best Medical Writer When You Are Hiring

1 year ago

ProMed Pharma marks one-year anniversary of Maple Grove labs

2 weeks ago

Exploring geographical variations in sperm quality in the continental US

7 months ago

FDA posts draft guidance for opioid-use disorder device developers

2 months ago
Medical-Writers-(-white-)

© Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.